2022 DW Insights and Inquiries archive
Explore DermWorld Insights and Inquiries articles by publication date.
December
December 28 - 2022: Best of DermWorld Insights and Inquiries
December 7 - Xylazine (“Tranq”): The potential for loss of life and limb
November
November 30 - Palmar Pagetoid dyskeratosis: A sheep in wolf’s clothing
November 16 - Unrestricted fascination with restrictive dermopathy
November 2 - Lipodystrophia semicircularis: A lipoatrophy not to get depressed about
October
October 26 - Lending a helping hand to our patients with Dupuytren’s disease
October 12 - Fixing the concept of the neutrophilic fixed drug eruption
September
September 21 - The emergence of rituximab-induced pyoderma gangrenosum: An alert to dermatologists
September 7 - BASCULE syndrome: Is something brewing with Bier spots?
August
August 31 - Metformin mania: Is it an adequate chemopreventive agent for skin cancer?
August 10 - Forty years of marriage, dermatology, inequities, and gratitude
August 3 - Infantile digital fibromatosis: Inclusions and exclusions
July
June
June 29 - When to see red in linear erythronychia — Malignant onychopapilloma
June 22 - Is it a waste for dermatologists to order fecal calprotectin?
June 15 - Aluminum can cause allergic contact dermatitis: Allergen of the Year 2022
June 8 - Sweating over acquired idiopathic generalized anhidrosis
May
May 18 - Coming to grips with lymphocytic thrombophilic arteritis
May 11 - Lagging ahead: LAG-3 checkpoint inhibition for advanced melanoma
April
March
March 30 - Bowel-associated dermatosis-arthritis syndrome (BADAS): The story behind the acronym
March 23 - A new wrinkle in the diagnosis of cystic fibrosis?
March 9 - IL-36 and generalized pustular psoriasis: L’chaim!
February
February 16 - Vascular Ehlers-Danlos syndrome: From rupture to rapture?
February 9 - Lightening the cutaneous and emotional burden of melasma: Cysteamine’s role
January
January 26 - Eccrine syringofibroadenoma: Sweating over the details
January 5 - Coming full circle (almost): Low dose oral minoxidil for alopecia
All content found on Dermatology World Insights and Inquiries, including: text, images, video, audio, or other formats, were created for informational purposes only. The content represents the opinions of the authors and should not be interpreted as the official AAD position on any topic addressed. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
DW Insights and Inquiries archive
Explore hundreds of Dermatology World Insights and Inquiries articles by clinical area, specific condition, or medical journal source.
All content solely developed by the American Academy of Dermatology
The American Academy of Dermatology gratefully acknowledges the support from Bristol Myers Squibb.
